Ebru Kocakaya

ORCID: 0000-0002-8347-3393
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Computational Drug Discovery Methods
  • Bioinformatics and Genomic Networks
  • Machine Learning in Bioinformatics
  • Respiratory viral infections research
  • Viral Infections and Immunology Research
  • Viral gastroenteritis research and epidemiology
  • Inflammasome and immune disorders
  • RNA and protein synthesis mechanisms
  • Turkish Literature and Culture
  • Linguistics and Cultural Studies
  • COVID-19 Clinical Research Studies
  • Microbial Metabolic Engineering and Bioproduction
  • Protein Structure and Dynamics
  • Cultural and Sociopolitical Studies
  • Heme Oxygenase-1 and Carbon Monoxide

Ankara University
2020-2021

Marek Ostaszewski Anna Niarakis Alexander Mazein Inna Kuperstein Robert D. Phair and 95 more Aurelio Orta‐Resendiz Vidisha Singh Sara Sadat Aghamiri Márcio Luís Acencio Enrico Glaab Andreas Ruepp Gisela Fobo Corinna Montrone Barbara Brauner Goar Frishman Luis Cristóbal Monraz Gómez Julia Somers Matti Hoch Shailendra K. Gupta Julia Scheel Hanna Borlinghaus Tobias Czauderna Falk Schreiber Arnau Montagud Miguel Ponce-de-León Akira Funahashi Yusuke Hiki Noriko Hiroi Takahiro Yamada Andreas Dräger Alina Renz Muhammad Naveez Zsolt Böcskei Francesco Messina Daniela Börnigen Liam Fergusson Marta Zaffira Conti Marius Rameil Vanessa Nakonecnij Jakob Vanhoefer Leonard Schmiester Muying Wang Emily E. Ackerman Jason E. Shoemaker Jeremy Zucker Kristie Oxford Jeremy Teuton Ebru Kocakaya Gökçe Yağmur Summak Kristina Hanspers Martina Kutmon Susan L. Coort Lars Eijssen Friederike Ehrhart Rex Devasahayam Arokia Balaya Denise Slenter Marvin Martens Nhung Pham Robin Haw Bijay Jassal Lisa Matthews M Orlic-Milacic Andrea Senff‐Ribeiro Karen Rothfels Veronica Shamovsky Ralf Stephan Cristoffer Sevilla Thawfeek Varusai Jean‐Marie Ravel Rupsha Fraser Vera Ortseifen Silvia Marchesi Piotr Gawron Ewa Smula Laurent Heirendt Venkata Satagopam Guanming Wu Anders Riutta Martin Golebiewski Stuart Owen Carole Goble Xiaoming Hu Rupert W. Overall Dieter Maier Angela Bauch Benjamin M. Gyori John A. Bachman Carlos Vega Valentin Grouès Miguél Vázquez Pablo Porras Luana Licata Marta Iannuccelli Francesca Sacco Anastasia Nesterova Anton Yuryev Anita de Waard Dénes Türei Augustin Luna Özgün Babur

We need to effectively combine the knowledge from surging literature with complex datasets propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets intervention. Here, we describe a large-scale community effort build an open access, interoperable computable repository COVID-19 molecular mechanisms. The Disease Map (C19DMap) is graphical, interactive representation disease-relevant mechanisms linking many sources. Notably, it computational...

10.15252/msb.202110387 article EN cc-by Molecular Systems Biology 2021-10-01

Ribavirin is a guanosine analog with broad-spectrum antiviral activity against RNA viruses. Based on this, we aimed to show the anti-SARS-CoV-2 of this drug molecule via in vitro, silico, and molecular techniques. showed Vero E6 cells following SARS-CoV-2 infection, whereas itself did not any toxic effect over concentration range tested. In silico analysis suggested that ribavirin has impact SARS-CoV-2, acting at different viral proteins. According detailed techniques, was shown decrease...

10.1139/cjpp-2020-0734 article EN cc-by Canadian Journal of Physiology and Pharmacology 2021-03-09
Marek Ostaszewski Anna Niarakis Alexander Mazein Inna Kuperstein Robert D. Phair and 95 more Aurelio Orta‐Resendiz Vidisha Singh Sara Sadat Aghamiri Márcio Luís Acencio Enrico Glaab Andreas Ruepp Gisela Fobo Corinna Montrone Barbara Brauner Goar Frishman Luis Cristóbal Monraz Gómez Julia Somers Matti Hoch Shailendra K. Gupta Julia Scheel Hanna Borlinghaus Tobias Czauderna Falk Schreiber Arnau Montagud Miguel Ponce-de-León Akira Funahashi Yusuke Hiki Noriko Hiroi Takahiro Yamada Andreas Dräger Alina Renz Muhammad Naveez Zsolt Böcskei Francesco Messina Daniela Börnigen Liam Fergusson Marta Zaffira Conti Marius Rameil Vanessa Nakonecnij Jakob Vanhoefer Leonard Schmiester Muying Wang Emily E. Ackerman Jason E. Shoemaker Jeremy Zucker Kristie Oxford Jeremy Teuton Ebru Kocakaya Gökçe Yağmur Summak Kristina Hanspers Martina Kutmon Susan L. Coort Lars Eijssen Friederike Ehrhart Rex Devasahayam Arokia Balaya Denise Slenter Marvin Martens Nhung Pham Robin Haw Bijay Jassal Lisa Matthews M Orlic-Milacic Andrea Senff‐Ribeiro Karen Rothfels Veronica Shamovsky Ralf Stephan Cristoffer Sevilla Thawfeek Varusai Jean‐Marie Ravel Rupsha Fraser Vera Ortseifen Silvia Marchesi Piotr Gawron Ewa Smula Laurent Heirendt Venkata Satagopam Guanming Wu Anders Riutta Martin Golebiewski Stuart Owen Carole Goble Xiaoming Hu Rupert W. Overall Dieter Maier Angela Bauch Benjamin M. Gyori John A. Bachman Carlos Vega Valentin Grouès Miguél Vázquez Pablo Porras Luana Licata Marta Iannuccelli Francesca Sacco Anastasia Nesterova Anton Yuryev Anita de Waard Dénes Türei Augustin Luna Özgün Babur

Abstract We describe a large-scale community effort to build an open-access, interoperable, and computable repository of COVID-19 molecular mechanisms - the Disease Map. discuss tools, platforms, guidelines necessary for distributed development its contents by multi-faceted biocurators, domain experts, bioinformaticians, computational biologists. highlight role relevant databases text mining approaches in enrichment validation curated mechanisms. Map their relevance pathophysiology...

10.1101/2020.10.26.356014 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2020-10-28

Abstract Ribavirin is a guanosine analog and has broad-spectrum antiviral activity against RNA viruses. Based on this, we aimed to show the anti-SARS-CoV-2 of this drug molecule via in vitro, silico molecular techniques. showed Vero E6 cells following SARS-CoV-2 infection. In analysis suggested that Ribarivin impact cells. According detailed techniques, was shown decrease TMPRSS2 expression both at mRNA protein level 48 hours after treatment. The suppressive effect ACE2 be dependent cell...

10.1101/2020.12.04.410092 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-12-05

Abstract Heme oxygenase-1 (HO-1) is a stress-induced enzyme that catalyzes the breakdown of heme into biliverdin, carbon monoxide, and iron. Targeting HO-1 to treat severe COVID-19 has been suggested by several groups, yet role in SARS-CoV-2 infection remains unclear. Based on this, we aimed investigate antiviral activity Hemin, an activator HO-1. Infectivity was decreased Vero E6 cells treated with Hemin. Hemin also TMPRSS2 ACE2 mRNA levels non-infected cells, possibly explaining observed...

10.1101/2022.05.24.493187 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-05-25
Coming Soon ...